These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 817426)

  • 21. [Cerebral lesions of malaria in children].
    Lemercier G; Rey M; Collomb H
    Bull Soc Pathol Exot Filiales; 1966; 59(4):533-48. PubMed ID: 4863483
    [No Abstract]   [Full Text] [Related]  

  • 22. [Plasmodium falciparum drug resistance and sulfadoxine-pyrimethamine in Africa].
    Randriamanjaka JR; Le Bras J; Charmot G; Coulaud JP
    Bull Soc Pathol Exot Filiales; 1989; 82(3):381-4. PubMed ID: 2670291
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Methylene blue inhibits lumefantrine-resistant Plasmodium berghei.
    Mwangi VI; Mumo RM; Kiboi DM; Omar SA; Ng'ang'a ZW; Ozwara HS
    J Infect Dev Ctries; 2016 Jun; 10(6):635-42. PubMed ID: 27367013
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Transmission of four Central American strains of Plasmodium vivax from monkey to man.
    Collins WE; Contacos PG; Krotoski WA; Howard WA
    J Parasitol; 1972 Apr; 58(2):332-5. PubMed ID: 4623380
    [No Abstract]   [Full Text] [Related]  

  • 25. Within-Host Selection of Drug Resistance in a Mouse Model of Repeated Incomplete Malaria Treatment: Comparison between Atovaquone and Pyrimethamine.
    Nuralitha S; Siregar JE; Syafruddin D; Roelands J; Verhoef J; Hoepelman AI; Marzuki S
    Antimicrob Agents Chemother; 2016 Jan; 60(1):258-63. PubMed ID: 26503662
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cerebral malaria--a clinicopathological study.
    Gopinathan VP; Ganguly SB; Chivukula LK
    J Assoc Physicians India; 1986 Jul; 34(7):473-5. PubMed ID: 3531155
    [No Abstract]   [Full Text] [Related]  

  • 27. [Studies on resistance formation toward Plasmodium berghei in mice].
    Scheepers-Biva M; Bafort J; Vincke IH
    Z Tropenmed Parasitol; 1967 Apr; 18(1):45-7. PubMed ID: 5589384
    [No Abstract]   [Full Text] [Related]  

  • 28. Cerebral malaria.
    Lancet; 1991 May; 337(8752):1281-4. PubMed ID: 1674076
    [No Abstract]   [Full Text] [Related]  

  • 29. Sulfadoxine-pyrimethamine resistant malaria from west or central Africa.
    Gubler J
    Br Med J (Clin Res Ed); 1988 Feb; 296(6619):433. PubMed ID: 3125942
    [No Abstract]   [Full Text] [Related]  

  • 30. [Treatment of Plasmodium falciparum malaria in Africa (except cerebral malaria)].
    Charmot G; Coulaud JP
    Med Trop (Mars); 1990; 50(1):103-8. PubMed ID: 2195275
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Malaria Surveillance - United States, 2015.
    Mace KE; Arguin PM; Tan KR
    MMWR Surveill Summ; 2018 May; 67(7):1-28. PubMed ID: 29723168
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Human malaria (Plasmodium falciparum) in owl monkeys (Aotus trivirgatus).
    Voller A; Hawkey CM; Richards WH; Ridley DS
    J Trop Med Hyg; 1969 Jul; 72(7):153-60. PubMed ID: 4978679
    [No Abstract]   [Full Text] [Related]  

  • 33. Low dosages of interleukin 1 protect mice against lethal cerebral malaria.
    Curfs JH; van der Meer JW; Sauerwein RW; Eling WM
    J Exp Med; 1990 Nov; 172(5):1287-91. PubMed ID: 2230643
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Plasmodium falciparum resistant to sulfadoxine/pyrimethamine in Senegal].
    Botella de Maglia J; Valls Ferrer JM; Martínez Paz ML; Espacio Casanovas A
    An Med Interna; 1991 Feb; 8(2):79-81. PubMed ID: 1893008
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mouse models for erythrocytic-stage malaria.
    Sanni LA; Fonseca LF; Langhorne J
    Methods Mol Med; 2002; 72():57-76. PubMed ID: 12125155
    [No Abstract]   [Full Text] [Related]  

  • 36. Physiological and morphological characters in two pyrimethamine-resistant lines of Plasmodium berghei SP11 after cryopreservation.
    Jadin J; Timperman G; De Ruysser F
    Trans R Soc Trop Med Hyg; 1976; 70(3):235-7. PubMed ID: 790672
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Within-host selection of drug resistance in a mouse model of repeated interrupted treatment of Plasmodium yoelii infection.
    Nuralitha S; Siregar JE; Syafruddin D; Hoepelman AIM; Marzuki S
    Malar J; 2017 May; 16(1):216. PubMed ID: 28535797
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Studies on the transmission of simian malaria and on a natural infection of man by Plasmodium simium in Brazil].
    Deane LM; Paumgartten Deane M; Ferreira Neto J
    Bol Oficina Sanit Panam; 1967 Aug; 63(2):100-5. PubMed ID: 4233427
    [No Abstract]   [Full Text] [Related]  

  • 39. Comments on human Plasmodia.
    Jeffery GM
    Mil Med; 1969 Sep; 134(10):821-4. PubMed ID: 4987061
    [No Abstract]   [Full Text] [Related]  

  • 40. Some aspects on certain pathogenic agents in malaria.
    Onabanjo AO
    Bull Soc Pathol Exot Filiales; 1980; 73(3):247-54. PubMed ID: 6908854
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.